The effect of a walking bike on exercise capacity in patients with COPD and chronic heart failure
Completed
- Conditions
- chronic heart failureCOPD1001928010006436
- Registration Number
- NL-OMON35160
- Lead Sponsor
- Medisch Centrum Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
All patients:
45-80 yr, familiar with 6MWT;group 1COPD:
pulmonologist's diagnosis of COPD Gold II or III;group 2 chronic heart failure:
cardiologist's diagnosis of chronic heart failure NYHA 3 or 4
Exclusion Criteria
All patients:
Disability limiting the ability to walk
Need for oxygen supplementation during exercise
Being used to walking with walking aid;group 1 COPD:
exacerbation COPD last 6 wks
history of congestive heart failure;group 2 chronic heart failure:
cardiac deterioration leading to hospital admission last 6 weeks
COPD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The change (in meters) in 6 minute walking distance using a rollator versus a<br /><br>walking bike </p><br>
- Secondary Outcome Measures
Name Time Method <p>The changes in dyspnea (Borg), leg fatigue (Borg), heart rate, breathing<br /><br>frequency, pulse, oxygen saturation, and inspiratory capacity (IC) during the<br /><br>walking tests. Differences in levels of shame (Borg score) and satisfaction<br /><br>(adjusted QUEST score) with rollator vs walking bike. Differences between<br /><br>patients with COPD and chronic heart failure with respect to responses on<br /><br>walking with rollator versus walking bike. Baseline characteristics will be<br /><br>used to identify potential predictors of response.<br /><br></p><br>